Document is current
Any future updates will be listed below
-
Authors
Corneli, Amy
Perry, Brian
Des Marais, Andrea
Choi, Yujung
Chen, Hillary
Lilly, Rebecca
Ayers, Denae
Bennett, Jesse
Kestner, Lauren
Meade, Christina S.
Sachdeva, Nidhi
McKellar, Mehri S.
-
Clinical Trials BETA
Clinical trials referenced in this document:
nct04521920 at ClinicalTrials.govDocuments that mention this clinical trial
Participant perceptions on the acceptability and feasibility of a telemedicine-based HIV PrEP and buprenorphine/naloxone program embedded within syringe services programs: a qualitative descriptive evaluation
https://doi.org/10.1186/s12954-022-00718-1
-
Funding
Funding for this research was provided by:
The Duke Endowment
- License Information
-
More Information
Article History
Received: 8 September 2022
Accepted: 19 November 2022
First Online: 3 December 2022
Declarations
:
: The Duke University Health Sciences Institutional Review Board approved the study. We created a separate protocol for the acceptability and feasibility study and had different study team members interact with program participants than in the pilot study to reduce social desirability bias. Participants provided their oral informed consent for participating in the IDIs.
: Not applicable.
: The authors declare that they have no competing interests.
